Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica

https://doi.org/10.1016/S0300-2896(01)75074-0Get rights and content

First page preview

First page preview
Click to open first page preview

Bibliografía (183)

  • M. Cazzola et al.

    Should long acting beta-2-agonist be considered an alternative first choice option for the treatment and stable COPD?

    Respir Med

    (1999)
  • D.A. Mahler et al.

    Efficacy of salmeterol xinafoate in the treatment of COPD

    Chest

    (1999)
  • M.T. Newhouse

    Is theophylline obsolete?

    Chest

    (1990)
  • J.W. Jenne

    Teophylline is no more obsolete than two puffs qid of current beta-2 agonists

    Chest

    (1990)
  • D.E. Niewoehner

    Theophylline therapy. A continuing dilemma

    Chest

    (1990)
  • R.A. Matthay et al.

    Theophylline improves global cardiac function and reduces dyspnea in chronic obstructive lung disesase

    J Allergy Clin Immunol

    (1986)
  • J. Ramsdell

    Use of theophylline in the treatment of COPD

    Chest

    (1995)
  • J. Vestbo et al.

    Longterm effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

    Lancet

    (1999)
  • P.L. Paggiaro et al.

    Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease

    Lancet

    (1998)
  • M. Miravitlles et al.

    Estado actual del tratamiento sustitutivo en el enfisema congénito por déficit de alfa-1-antitripsina. Informe del registro nacional

    Arch Bronconeumol

    (1999)
  • T. Montemayor et al.
  • N.M. Siafakas et al.

    Optimal assessment and management of chronic obstructive pulmonary disease (COPD)

    Eur Respir J

    (1995)
  • Society American Thoracic

    Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1995)
  • G.L. Snider et al.

    The definition of emphysema: report of National Heart and Blood Institute, division of Lung Diseases, workshop

    Am Rev Respir Dis

    (1985)
  • Lung function testing: selection of reference values and interpretative strategies

    Am Rev Respir Dis

    (1991)
  • Guidelines for the management of chronic obstructive pulmonary disease

    Thorax

    (1997)
  • B.R. Celli

    Monitoring the progression of chronic obstructive pulmonary disease: time for a new staging system

    Eur Respir Rev

    (1999)
  • B. Celli et al.

    The SCORE: a new COPD staging system combining 6MWD, MRC dyspnea. FEV1 and PaO2 as predictor of health care resources utilization (HCUR)

    Am J Respir Crit Care Med

    (2000)
  • J.F. Masa et al.

    Underdiagnosis and geographical differences in COPD prevalence in Spain

    Am J Respir Crit Care Med

    (1999)
  • L. Biglino et al.
  • V. Sobradillo

    Enfermedad pulmonar obstructiva crónica. Enfoque actual

  • Informe del Gabinete de Estudios Sociológicos Bernard Krief. SEPAR

    (1995)
  • P. Alonso
  • M.G. Seneff et al.

    Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease

    Jama

    (1995)
  • J.C. Hogg et al.

    Site and nature of airway obstruction in chronic obstructive lung disease

    N Engl J Med

    (1968)
  • M.G. Cosio et al.

    The relations between structural changes in small airways and pulmonary function tests

    N Engl J Med

    (1978)
  • R. Filkenstein et al.

    Alveolar inflammation and its relation to emphysema in smokers

    Am J Respir Crit Care Med

    (1995)
  • T.C. O'Shaughnessy et al.

    Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1

    Am J Respir Crit Care Med

    (1997)
  • M. Saetta et al.

    CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1998)
  • V.I. Peinado et al.

    Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1999)
  • D.S. Robinson et al.

    Predominant TH2-like broncho-alveolar T-lymphocite population in atopic asthma

    N Engl J Med

    (1992)
  • M. Humbert et al.

    IL-4 and IL-5 mRNA and protein in bronchial biopsies from atopic and non atopic asthma. Evidence against “intrinsic” asthma beign a distinct immunopathological entity

    Am J Respir Crit Care Med

    (1996)
  • V.M. Keatings et al.

    Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma

    Am J Respir Crit Care Med

    (1996)
  • A.T. Hill et al.

    The interrelationship of sputum inflammatory markers in patients with chronic bronchitis

    Am J Respir Crit Care Med

    (1999)
  • M.R. Lang et al.

    Collagen content of alveolar wall tissue in emphysematous and non-emphysematous lungs

    Thorax

    (1994)
  • W. Timens et al.

    Extracellular matrix and inflammation: a role of fibroblast-mediated tissue repair in the pathogenesis of emphysema

    Eur Respir Rev

    (1997)
  • W.D. Kim et al.

    Centrilobular and panlobular emphysema in smokers. Two distinct morphologic and functional entities

    Am Rev Respir Dis

    (1991)
  • J.A. Barberà et al.

    Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease

    Am J Respir Crit Care Med

    (1994)
  • V.I. Peinado et al.

    Endothelial dysfunction in pulmonary arteries of patients with mild COPD

    Am J Physiol

    (1998)
  • A.T. Dinh-Xuan et al.

    Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease

    N Engl J Med

    (1991)
  • Cited by (142)

    View all citing articles on Scopus
    View full text